Saffron
Crocus sativus
TL;DR
Saffron at 30 mg/day has repeatedly matched fluoxetine and imipramine in head-to-head trials for mild to moderate depression. The trials are small, short and overwhelmingly Iranian, which is the main reason to hold the finding loosely.
Ideal For
- Mild to moderate depression, alongside proper clinical care
- SSRI-induced sexual dysfunction
- Premenstrual mood and physical symptoms
- Early age-related macular degeneration
Avoid If
- Severe depression or suicidal ideation — this needs urgent clinical care
- Pregnancy — high doses are abortifacient
- Bipolar disorder, without psychiatric supervision
- Taking an SSRI, without medical advice
Frequently Asked Questions
Overview
Saffron has an unusual evidence profile: a botanical that has been tested head-to-head against prescription antidepressants, repeatedly, and held its own. Randomised double-blind trials at 30 mg/day of standardised extract have compared saffron with fluoxetine 20-40 mg and with imipramine 100 mg in mild to moderate depression, finding no significant difference in Hamilton Depression Rating Scale improvement, while saffron produced fewer side effects — notably less sexual dysfunction, which is a common reason people stop SSRIs. Meta-analyses of these trials report a large effect versus placebo and equivalence versus antidepressants. The caveats are substantial and should be stated plainly: nearly all trials come from a handful of Iranian research groups in a saffron-producing country, sample sizes are typically 40-60 participants, durations are six to eight weeks, and independent replication outside that setting is limited. Saffron also has smaller supportive literatures for premenstrual symptoms, sexual dysfunction including SSRI-induced dysfunction, and age-related macular degeneration, where crocin appears to improve retinal function. It is expensive by weight, but the dose is small, and adulteration with safflower or dyed plant material is a real problem in the market.
How It Works
- Crocin and safranal inhibit serotonin, dopamine and noradrenaline reuptake
- Increases hippocampal BDNF expression in animal models
- Antioxidant activity reduces neuroinflammation
- Crocin protects retinal photoreceptors and improves retinal flow
Quick Facts
- Matched fluoxetine and imipramine in head-to-head trials
- 30 mg/day is the studied dose — small, and cost-effective at that level
- Trials are small, short and mostly from Iranian groups
- Adulteration is common; buy standardised extract
Benefits & Outcomes
Mood & Mental Health Support
Saffron has the strongest herbal antidepressant evidence, matching fluoxetine and imipramine in multiple head-to-head RCTs for mild-to-moderate depression.
Depression Symptom Reduction
Saffron performs comparably to low-dose SSRIs for mild-to-moderate depression across several randomised trials.
Obsessive Thought Reduction
Saffron has real antidepressant data but almost nothing specific to obsessive thinking.
Pleasure Response Restoration
Saffron is the supplement with the most credible antidepressant data, and mood improvement includes anhedonia items.
Serotonin Support
Saffron is the better-evidenced serotonergic supplement, with fewer safety landmines than 5-HTP.
Sexual Arousal
Saffron has decent evidence specifically for antidepressant-induced sexual dysfunction.
Social Anxiety Reduction
Saffron shows antidepressant and anxiolytic signals in small trials.
Stress & Anxiety Reduction
Saffron has promising small trials for mood and anxiety.
Seasonal Mood Support
Saffron has surprisingly consistent antidepressant trial data for a spice.
Health Concerns Addressed
Depression
Among the few botanicals tested directly against prescription antidepressants and not beaten — but the trials are small, short and geographically concentrated.
Irritability & Mood Swings
Saffron has surprisingly consistent RCT evidence for mild-to-moderate depressive and premenstrual mood symptoms, with several small trials showing effects comparable to low-dose antidepressants. Replication by independent groups is limited, and it addresses mood broadly rather than the specific drivers of irritability like sleep and blood sugar.
Low Motivation
Saffron has surprisingly consistent trial evidence for mild to moderate depressive symptoms, including anhedonia, which is the component most closely tied to low motivation. Trials are small and often industry-linked.
Postpartum Depression
Saffron has a small randomised trial in postpartum depression showing improvement comparable to fluoxetine — genuinely interesting evidence — but small trials are not a foundation for treating a serious condition, and therapy plus proven medication remain the standard.
Supporting Research17 studies
The Efficacy of Saffron in the Treatment of Mild to Moderate Depression: A Meta-analysis
Toth B, Hegyi P, Lantos T +11 more
Saffron reduced depressive symptoms compared with placebo and was non-inferior to conventional antidepressants in mild to moderate depression.
Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women
Gout B, Bourges C, Paineau-Dubreuil S
Satiereal caused a significantly greater body weight reduction
affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial
Kell G, et al
affron increased mood, reduced anxiety and managed stress without side effects, offering a natural alternative to standard treatments.
Saffron for major depressive disorder and anhedonia: a systematic review and meta-analysis
Hausenblas HA, Saha D, Dubyak PJ +1 more
Saffron significantly outperformed placebo and matched standard antidepressants on depression severity
Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis
Marx W, Lane M, Rocks T
Saffron could be an effective intervention for symptoms of depression and anxiety; however, due to evidence of publication bias and lack of regional diversity, further trials are required.
A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression
Mazidi M
Saffron appears to have a significant impact in the treatment of anxiety and depression disorder.
Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial
Agha-Hosseini M, Kashani L, Aleyaseen A +4 more
The results of this study indicate the efficacy of C. sativus L. in the treatment of PMS.
An examination into the mental and physical effects of a saffron extract (affron) in recreationally-active adults
Lopresti AL
There were no statistically significant between-group differences in changes in any of the outcome measures.
Effect of Crocus sativus Extract Supplementation in the Metabolic Control of People with Diabetes Mellitus Type 1: A Double-Blind Randomized Placebo-Controlled Trial
Crocus sativus extract supplementation produced only small metabolic changes in people with type 1 diabetes.
Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials
Hausenblas HA, Saha D, Dubyak PJ +1 more
Saffron supplementation significantly reduced depression symptom scores versus placebo and performed comparably to standard antidepressants.
A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression
Akhondzadeh S, Mostafavi SA, Keshavarz SA +2 more
Participants were randomly assigned into one of the two groups receiving daily either 30 mg of Crocus sativus capsules (15 mg twice/day) or placebo capsules (twice/day).
Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action
Lopresti AL, Drummond PD
Clinical studies consistently favour saffron over placebo, with proposed serotonergic, anti-inflammatory and neuroprotective mechanisms.
Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial
Jackson PA, Forster J, Khan J +14 more
Saffron extract produced no significant change on most primary mood measures in healthy adults.
Herbal Dietary Supplements for Erectile Dysfunction: A Systematic Review and Meta-Analysis
Borrelli F, Colalto C, Delfino DV +2 more
saffron and T. terrestris treatment produced mixed results
The effects of an oral saffron extract on psychological well-being in healthy adults with low mood: a randomised, double-blind, placebo-controlled study
Kell G, Rao A, Beccaria G +3 more
A standardised saffron extract improved mood and reduced stress and anxiety scores in healthy adults with low mood over four weeks.
An investigation into an evening intake of a saffron extract (affron) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: a randomised, double-blind, placebo-controlled, multi-dose study
Lopresti AL, et al.
These results provide further validation of the sleep-enhancing effects of 28-days of saffron supplementation in adults with unsatisfactory sleep.
Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial
Akhondzadeh S, Fallah-Pour H, Afkham K +2 more
Saffron 30 mg/day was as effective as imipramine 100 mg/day over six weeks, with fewer anticholinergic side effects.
Safety Information
Potential Side Effects
At 30 mg/day, mild and infrequent: nausea, appetite change, headache, dry mouth. Higher doses cause vomiting, dizziness and, at gram-level doses, serious toxicity including bleeding.
Contraindications
Pregnancy, where high doses stimulate uterine contraction. Bipolar disorder without supervision, given the theoretical switch risk of any antidepressant action. Do not use as a substitute for treatment in severe depression.
Drug Interactions
- SSRIs and SNRIs — additive serotonergic effect; use only with medical supervision
- MAOIs — avoid
- Anticoagulants — antiplatelet activity at higher doses
- Antihypertensives — mild additive blood pressure lowering
Pregnancy & Breastfeeding
Pregnancy: likely_unsafe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
30-30 mg
Best Time to Take
15 mg twice daily with meals
Best Form
Standardised stigma extract (affron, Safr'Inside or equivalent), 30 mg/day
Bioavailability
Crocin is hydrolysed to crocetin, which is well absorbed and crosses the blood-brain barrier; safranal is absorbed directly.
Forms Compared
Standardised extract 30 mg
Affron (28 mg)
Whole saffron threads
Saffron with curcumin
Food & Timing
With meals; splitting into two doses matches the trial protocols.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.